Literature DB >> 18366312

Near full-length genomic analysis of a novel subtype A1/C recombinant HIV type 1 isolate from Canada.

Michel Ntemgwa1, Thomas D'Aquin Toni, Bluma G Brenner, Jean-Pierre Routy, Daniela Moisi, Maureen Oliveira, Mark A Wainberg.   

Abstract

The rapid introduction of non-B HIV-1 subtypes into Quebec, mostly from persons from regions where HIV prevalence is high and where different variants circulate, means that recombination must now be an important consideration in the epidemiologic surveillance of HIV infection. No circulating recombinant form (CRF), currently involving exclusively subtypes A1 and C, exists in the Los Alamos HIV database. This study presents a near full-length genomic analysis of a novel HIV-1 recombinant involving subtypes A1 and C. Bootscanning revealed that the recombinant structure involves three breakpoints that separate the genome into four regions, alternating between subtypes A1 and C. The intersubtype recombinant breakpoint in the pol gene was at midpoint between the protease and reverse transcriptase open reading frames. This is the first report of a recombinant involving subtypes A1 and C in Canada, the epidemiologic significance of which is not yet known.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18366312     DOI: 10.1089/aid.2007.0282

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  2 in total

1.  Novel HIV-1 recombinant forms in antenatal cohort, Montreal, Quebec, Canada.

Authors:  Mathieu Quesnel-Vallières; Iman Kouzayha; Evelyne Tran; Issatou Barry; Charlène Lasgi; Natacha Merindol; Vanessa Monteil; Doris G Ransy; Marc Boucher; Normand Lapointe; Hugo Soudeyns
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

2.  Molecular and phylogeographic analysis of human immuno-deficiency virus type 1 strains infecting treatment-naive patients from Kigali, Rwanda.

Authors:  John Rusine; Suzanne Jurriaans; Janneke van de Wijgert; Marion Cornelissen; Brenda Kateera; Kimberly Boer; Etienne Karita; Odette Mukabayire; Menno de Jong; Pascale Ondoa
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.